The store will not work correctly when cookies are disabled.
4-(2-((2-(2-Methoxyphenoxy)ethyl)amino)ethyl)benzene-1,2-diol
ID: ALA3797758
PubChem CID: 127047996
Max Phase: Preclinical
Molecular Formula: C17H21NO4
Molecular Weight: 303.36
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccccc1OCCNCCc1ccc(O)c(O)c1
Standard InChI: InChI=1S/C17H21NO4/c1-21-16-4-2-3-5-17(16)22-11-10-18-9-8-13-6-7-14(19)15(20)12-13/h2-7,12,18-20H,8-11H2,1H3
Standard InChI Key: RNAXJKKVCJEZIO-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3383 -1.3500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.3383 1.3500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.6003 1.4977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8990 0.7455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2003 1.4932 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.4990 0.7409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.8003 1.4887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.0990 0.7364 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-10.4003 1.4841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.6994 0.7341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-12.9984 1.4841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-12.9985 2.9841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.6994 3.7341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.4004 2.9842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.7025 -0.7667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-12.7426 -1.3652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
1 6 2 0
1 7 1 0
2 8 1 0
9 10 1 0
12 13 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
15 20 2 0
14 15 1 0
21 22 1 0
16 21 1 0
13 14 1 0
11 12 1 0
10 11 1 0
4 9 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 303.36 | Molecular Weight (Monoisotopic): 303.1471 | AlogP: 2.32 | #Rotatable Bonds: 8 |
Polar Surface Area: 70.95 | Molecular Species: BASE | HBA: 5 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.90 | CX Basic pKa: 9.15 | CX LogP: 1.96 | CX LogD: 0.60 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.52 | Np Likeness Score: 0.10 |
References
1. Weichert D, Stanek M, Hübner H, Gmeiner P.. (2016) Structure-guided development of dual β2 adrenergic/dopamine D2 receptor agonists., 24 (12): [PMID:27132867] [10.1016/j.bmc.2016.04.028] |